Caligan Partners LP - Sep 30, 2025 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager: Caligan Partners LP
Reporting Manager: Caligan Partners LP
Security: Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: AVTX
Shares outstanding: 13.2M shares
Disclosed Ownership: 833K shares
Ownership: 6.3%
Form type: SCHEDULE 13G
Date filed: 11/14/2025, 02:31 PM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Caligan Partners LP	6.3%	833K	0	833K	/s/ David Johnson	David Johnson, Managing Partner
David Johnson	6.3%	833K	0	833K	/s/ David Johnson	David Johnson, Individually